|
Status |
Public on Aug 16, 2021 |
Title |
A novel therapeutic strategy targeting the mesenchymal phenotype of malignant pleural mesothelioma by suppressing LSD1 [ATAC-seq] |
Organism |
Homo sapiens |
Experiment type |
Genome binding/occupancy profiling by high throughput sequencing
|
Summary |
ATAC-seq analysis of following knock down of LSD1 in ACC-MESO-1 cells.
|
|
|
Overall design |
We performed ATAC-seq analysis in ACC-MESO-1 cell infected with shLSD1 or control.
|
|
|
Contributor(s) |
Tajima K, Wirawan A |
Citation(s) |
34593606 |
|
Submission date |
Aug 15, 2021 |
Last update date |
Nov 15, 2021 |
Contact name |
Ken Tajima |
E-mail(s) |
tajiken@juntendo.ac.jp
|
Phone |
+81-3-5802-1063
|
Organization name |
Juntendo University
|
Department |
Department of Respiratory Medicine
|
Street address |
2-1-1 Hongo
|
City |
Bunkyo-Ku |
State/province |
Tokyo |
ZIP/Postal code |
113-0033 |
Country |
Japan |
|
|
Platforms (1) |
GPL18573 |
Illumina NextSeq 500 (Homo sapiens) |
|
Samples (4)
|
|
This SubSeries is part of SuperSeries: |
GSE182154 |
A novel therapeutic strategy targeting the mesenchymal phenotype of malignant pleural mesothelioma by suppressing LSD1 |
|
Relations |
BioProject |
PRJNA754805 |
SRA |
SRP332633 |